PedAM
Pediatric Disease Annotations & Medicines
| Disease | lymphoma |
| Symptom | C0426768|o sign |
| Sentences | 13 |
| PubMedID- 24216491 | The purposes of this study were to describe cases of feline gastric lymphoma with regards to signalment, clinical presentation, laboratory and ancillary study findings, response to therapy, and outcomes and to identify prognostic variables. |
| PubMedID- 24721419 | Several reports have indicated that patients receiving anti-tnf antibody therapy had no significantly increased risk of developing malignant lymphoma . |
| PubMedID- 26000056 | When the 5 h interval was used, the nanotherapy was more efficacious than rituximab and led to complete eradication of lymphoma cells with no signs of metastasis or disease recurrence. |
| PubMedID- 21715359 | Previously established risk factors were also significantly associated with lymphoma development in this cohort (table 1). |
| PubMedID- 26557260 | There were no signs of recurrence of lymphoma on the following pet scan. |
| PubMedID- 20110857 | Two hla-b mismatches were also significantly associated with lymphoma in the kidney (hr 2.82, p=0.009). |
| PubMedID- 25312719 | No significant difference between os of cats with nasal lymphoma and that of cats with other tumours was observed. |
| PubMedID- 20205760 | There were no signs of hodgkin's lymphoma in the bone marrow and bone aspiration test results. |
| PubMedID- 24367763 | B gwas studies in acute lymphoblastic leukemia (childhood) (36–39), chronic myeloid leukemia (40), and large b-cell lymphoma (41) with no significant findings reported in the mhc region. |
| PubMedID- 24497088 | Conclusion: semi-automatic volumetry and bi-dimensional who significantly reduce the number of incorrectly classified lymphoma patients by approximately 9.6% in the multicenter setting in comparison to linear parameters. |
| PubMedID- 24521793 | Immunophenotypes and who stagesof the cases indicated no significance in survival of cats with lymphoma in the presentstudy. |
| PubMedID- 21611191 | Tumor watch analysis of lck-casp9dn mice for up to 90 weeks showed very low penetrance of lymphoma with no significant difference between beclin 1 wild type and heterozygous mice (figure 6b). |
| PubMedID- 21769323 | The patient is currently being followed as an outpatient without additional adjuvant chemotherapy, however, the patient shows no sign of recurrence of malt lymphoma and her serum il2-recepter levels remain within the normal limits. |
Page: 1